Home > Press Releases > Medical AI Governance Market

Medical AI Governance Market Likely to Surpass USD 1.9 Billion by 2035

Report Code: HC-48758  |  Published in: Sep 2026, By MarketGenics  |  Number of pages: 316
Get PDF
Buy

Global Medical AI Governance Market Forecast 2035:

According to the report, the global medical AI governance market is likely to grow from USD 0.3 Billion in 2025 to USD 1.9 Billion in 2035 at a highest CAGR of 21.7% during the time period. Medical AI governance is gaining pace as healthcare organizations extend AI to diagnosis, clinical decision support, medical devices, patient monitoring, and administrative processes. As the adoption of AI grows, the necessity for structured risk assessment, model validation, transparency and accountability, cybersecurity, human oversight, and lifecycle management become increasingly crucial to ensure that AI systems are safe and effective in clinical settings.

The potential for model drift, algorithmic bias, data privacy concerns, transparency, and unreliable outputs are driving a push for the implementation of continuous monitoring and governance processes in the healthcare domain. The growing adoption of generative and agentic AI is only adding to the need for controls in access to models, autonomous actions, data handling, auditability and incident management.

Adoption is also being encouraged by regulatory changes. Documented evidence of testing, performance, controls, and post-deployment monitoring are becoming increasingly commonplace and are necessary to meet regulatory, audit, purchasing, and internal compliance needs for healthcare organizations. Formalising an AI management system is also becoming a growing trend as per standardized frameworks like ISO/IEC 42001.

The clinical adoption of AI, changing regulations and increasing pressure for safety and accountability are fueling the demand for robust medical AI governance solutions.

“Key Driver, Restraint, and Growth Opportunity Shaping the Global Medical AI Governance Market

AI vendors are becoming a major part of the healthcare industry puzzle, and healthcare providers are taking the time to assess them before adopting solutions for clinical use. Model requirements, vendor accountability, security practices, validation evidence, update procedures, and contractual responsibilities are all motivating standardized practices for AI procurement, vendor assessment, etc.

Healthcare organizations may face shortages of professionals combining clinical knowledge, AI expertise, regulatory understanding, cybersecurity capabilities, and risk-management experience. The establishment of specific governance teams can be a resource-intensive process, and may take time to implement, especially in smaller hospitals and healthcare providers who lack technical capacity.

Medical AI Governance service providers can embed governance functions within the existing healthcare quality and compliance, risk-management, and clinical safety systems. AI inventories, approval workflows integration with incident management, audit documentation, and quality processes integration can eliminate duplication and integrate AI governance into the work that organizations do, which can lead to wider enterprise adoption.

Regional Analysis of Global Medical AI Governance Market

  • The demand for Medical AI Governance is highest in North America, where healthcare technology is well developed, a large number of AI-powered medical devices are deployed, and regulatory frameworks are established; and where institutional commitment to clinical safety and accountability is high. The U.S. FDA has specific AI-device oversight and lifecycle-management processes in place, resulting in constant needs for governance, validation and monitoring tools.
  • Asia Pacific is seeing the highest growth as hospitals and healthcare providers are embracing digital transformation and AI adoption, and building national policies for responsible AI. Structured governance capabilities are also required for new AI governance requirements driven by regional initiatives and the increasing importance of health-data standards, interoperability, workforce competency and readiness.
  • Europe is boasting robust growth as the EU AI Act takes effect Un August 2026, introducing greater governing, transparency, risk-management, and compliance standards for organisations using AI. The European Commission is also standardizing high-risk applications of AI, and the healthcare sector is being regulated together with medical devices, increasing the need for an established governance framework for AI.

Key players in the global Medical AI Governance market include prominent companies such as Pacific AI, ALIGNMT AI, Amazon Web Services, Complira, Credo AI, Ferrum Health, Fiddler AI, Google, IBM, Microsoft, Newton’s Tree, Onboard AI, Signal 1, Synergist Technology, Others, Other Key Players.

The global medical AI governance market has been segmented as follows:

Global Medical AI Governance Market Analysis, by Governance Type

  • AI Risk Management Governance
  • Clinical AI Governance
  • Data Governance
  • Model Governance
  • Algorithm Governance
  • Ethical AI Governance
  • Regulatory Compliance Governance
  • Privacy Governance
  • Transparency & Explainability Governance
  • Others

Global Medical AI Governance Market Analysis, by Technology

  • Machine Learning
  • Natural Language Processing (NLP)
  • Computer Vision
  • Explainable AI (XAI)
  • Generative AI / LLM Governance
  • Predictive Analytics
  • Reinforcement Learning
  • Multimodal AI
  • Agentic AI
  • Others

Global Medical AI Governance Market Analysis, by Deployment Mode

  • Cloud-based
  • On-Premise
  • Hybrid

Global Medical AI Governance Market Analysis, by AI Model

  • Diagnostic & Medical Imaging AI Models
  • Clinical Decision Support Systems
  • Predictive Risk-Scoring Models
  • Conversational Health Assistants
  • Administrative & Operational AI
  • Drug Discovery & Clinical Trial AI Models
  • Others

Global Medical AI Governance Market Analysis, by Risk Classification

  • Critical AI Systems
  • Limited-Risk AI Systems
  • Minimal-Risk AI Systems

Global Medical AI Governance Market Analysis, by Regulatory Framework Alignment

  • HIPAA
  • FDA
  • EU AI Act
  • EU MDR / IVDR
  • ISO/IEC 42001
  • NIST AI Risk Management Framework
  • GDPR
  • Others

Global Medical AI Governance Market Analysis, by Organization Size

  • Large Enterprises
  • Small & Medium-Sized Enterprises

Global Medical AI Governance Market Analysis, by End Users

  • Hospitals & Health Systems
  • Pharmaceutical & Biotechnology Companies
  • Payers & Health Insurers
  • Diagnostic & Imaging Centers
  • Medical Device & Digital Health Companies
  • Research Institutions & Academic Medical Centers
  • Government & Public Health Agencies
  • Clinics & Ambulatory Care Centers
  • Others

Global Medical AI Governance Market Analysis, by Region

  • North America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • South America

About Us

MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.

Contact US

USA Address:

800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.

+1(302)303-2617

info@marketgenics.co

India Address:

3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.

sales@marketgenics.co

Table of Contents

  • 1. Research Methodology and Assumptions
    • 1.1. Definitions
    • 1.2. Research Design and Approach
    • 1.3. Data Collection Methods
    • 1.4. Base Estimates and Calculations
    • 1.5. Forecasting Models
      • 1.5.1. Key Forecast Factors & Impact Analysis
    • 1.6. Secondary Research
      • 1.6.1. Open Sources
      • 1.6.2. Paid Databases
      • 1.6.3. Associations
    • 1.7. Primary Research
      • 1.7.1. Primary Sources
      • 1.7.2. Primary Interviews with Stakeholders across Ecosystem
  • 2. Executive Summary
    • 2.1. Global Medical AI Governance Market Outlook
      • 2.1.1. Medical AI Governance Market Size Value (US$ Bn), and Forecasts, 2021-2035
      • 2.1.2. Compounded Annual Growth Rate Analysis
      • 2.1.3. Growth Opportunity Analysis
      • 2.1.4. Segmental Share Analysis
      • 2.1.5. Geographical Share Analysis
    • 2.2. Market Analysis and Facts
    • 2.3. Supply-Demand Analysis
    • 2.4. Competitive Benchmarking
    • 2.5. Go-to- Market Strategy
      • 2.5.1. Customer/ End-use Industry Assessment
      • 2.5.2. Growth Opportunity Data, 2026-2035
        • 2.5.2.1. Regional Data
        • 2.5.2.2. Country Data
        • 2.5.2.3. Segmental Data
      • 2.5.3. Identification of Potential Market Spaces
      • 2.5.4. GAP Analysis
      • 2.5.5. Potential Attractive Price Points
      • 2.5.6. Prevailing Market Risks & Challenges
      • 2.5.7. Preferred Sales & Marketing Strategies
      • 2.5.8. Key Recommendations and Analysis
      • 2.5.9. A Way Forward
  • 3. Industry Data and Premium Insights
    • 3.1. Global Healthcare & Pharmaceutical Industry Overview, 2025
      • 3.1.1. Healthcare & Pharmaceutical Ecosystem Analysis
      • 3.1.2. Key Trends for Healthcare & Pharmaceutical Industry
      • 3.1.3. Regional Distribution for Healthcare & Pharmaceutical Industry
    • 3.2. Supplier Customer Data
    • 3.3. Technology Roadmap and Developments
  • 4. Market Overview
    • 4.1. Market Dynamics
      • 4.1.1. Drivers
        • 4.1.1.1. Rising adoption of AI and generative AI in clinical workflows
        • 4.1.1.2. Increasing regulatory and compliance requirements for medical AI
        • 4.1.1.3. Growing demand for AI transparency, risk management, and continuous monitoring
      • 4.1.2. Restraints
        • 4.1.2.1. High complexity and cost of implementing comprehensive AI governance frameworks
        • 4.1.2.2. Limited availability of specialized AI governance and healthcare compliance expertise
    •  4.2. Key Trend Analysis
    • 4.3. Regulatory Framework
      • 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
      • 4.3.2. Tariffs and Standards
      • 4.3.3. Impact Analysis of Regulations on the Market
    • 4.4. Ecosystem Analysis
    • 4.5. Porter’s Five Forces Analysis
    • 4.6. PESTEL Analysis
    • 4.7. Global Medical AI Governance Market Demand
      • 4.7.1. Historical Market Size – Value (US$ Bn), 2020-2024
      • 4.7.2. Current and Future Market Size - Value (US$ Bn), 2026–2035
        • 4.7.2.1. Y-o-Y Growth Trends
        • 4.7.2.2. Absolute $ Opportunity Assessment
  • 5. Competition Landscape
    • 5.1. Competition structure
      • 5.1.1. Fragmented v/s consolidated
    • 5.2. Company Share Analysis, 2025
      • 5.2.1. Global Company Market Share
      • 5.2.2. By Region
        • 5.2.2.1. North America
        • 5.2.2.2. Europe
        • 5.2.2.3. Asia Pacific
        • 5.2.2.4. Middle East
        • 5.2.2.5. Africa
        • 5.2.2.6. South America
    • 5.3. Product Comparison Matrix
      • 5.3.1. Specifications
      • 5.3.2. Market Positioning
      • 5.3.3. Pricing
  • 6. Global Medical AI Governance Market Analysis, by Governance Type
    • 6.1. Key Segment Analysis
    • 6.2. Medical AI Governance Market Size Value (US$ Bn), Analysis, and Forecasts, by Governance Type, 2021-2035
      • 6.2.1. AI Risk Management Governance
      • 6.2.2. Clinical AI Governance
      • 6.2.3. Data Governance
      • 6.2.4. Model Governance
      • 6.2.5. Algorithm Governance
      • 6.2.6. Ethical AI Governance
      • 6.2.7. Regulatory Compliance Governance
      • 6.2.8. Privacy Governance
      • 6.2.9. Transparency & Explainability Governance
      • 6.2.10. Others
  • 7. Global Medical AI Governance Market Analysis, by Technology
    • 7.1. Key Segment Analysis
    • 7.2. Medical AI Governance Market Size Value (US$ Bn), Analysis, and Forecasts, by Technology, 2021-2035
      • 7.2.1. Machine Learning
      • 7.2.2. Natural Language Processing (NLP)
      • 7.2.3. Computer Vision
      • 7.2.4. Explainable AI (XAI)
      • 7.2.5. Generative AI / LLM Governance
      • 7.2.6. Predictive Analytics
      • 7.2.7. Reinforcement Learning
      • 7.2.8. Multimodal AI
      • 7.2.9. Agentic AI
      • 7.2.10. Others
  • 8. Global Medical AI Governance Market Analysis, by Deployment Mode
    • 8.1. Key Segment Analysis
    • 8.2. Medical AI Governance Market Size Value (US$ Bn), Analysis, and Forecasts, by Deployment Mode, 2021-2035
      • 8.2.1. Cloud-Based
      • 8.2.2. On-Premises
      • 8.2.3. Hybrid
  • 9. Global Medical AI Governance Market Analysis and Forecasts, by AI Model
    • 9.1. Key Findings
    • 9.2. Medical AI Governance Market Size Value (US$ Bn), Analysis, and Forecasts, by AI Model, 2021-2035
      • 9.2.1. Diagnostic & Medical Imaging AI Models
      • 9.2.2. Clinical Decision Support Systems
      • 9.2.3. Predictive Risk-Scoring Models
      • 9.2.4. Conversational Health Assistants
      • 9.2.5. Administrative & Operational AI
      • 9.2.6. Drug Discovery & Clinical Trial AI Models
      • 9.2.7. Others
  • 10. Global Medical AI Governance Market Analysis and Forecasts, by Risk Classification
    • 10.1. Key Findings
    • 10.2. Medical AI Governance Market Size Value (US$ Bn), Analysis, and Forecasts, by Risk Classification, Next-Generation Sequencing (NGS)
      • 10.2.1. Critical AI Systems
      • 10.2.2. Limited-Risk AI Systems
      • 10.2.3. Minimal-Risk AI Systems
  • 11. Global Medical AI Governance Market Analysis and Forecasts, by Regulatory Framework Alignment
    • 11.1. Key Findings
    • 11.2. Medical AI Governance Market Size Value (US$ Bn), Analysis, and Forecasts, by Regulatory Framework Alignment, 2021-2035
      • 11.2.1. HIPAA
      • 11.2.2. FDA
      • 11.2.3. EU AI Act
      • 11.2.4. EU MDR / IVDR
      • 11.2.5. ISO/IEC 42001
      • 11.2.6. NIST AI Risk Management Framework
      • 11.2.7. GDPR
      • 11.2.8. Others
  • 12. Global Medical AI Governance Market Analysis and Forecasts, by Organization Size
    • 12.1. Key Findings
    • 12.2. Medical AI Governance Market Size Value (US$ Bn), Analysis, and Forecasts, by Organization Size, 2021-2035
      • 12.2.1. Large Enterprises
      • 12.2.2. Small & Medium-Sized Enterprises
  • 13. Global Medical AI Governance Market Analysis and Forecasts, by End-users
    • 13.1. Key Findings
    • 13.2. Medical AI Governance Market Size Value (US$ Bn), Analysis, and Forecasts, by End-users, 2021-2035
      • 13.2.1. Hospitals & Health Systems
      • 13.2.2. Pharmaceutical & Biotechnology Companies
      • 13.2.3. Payers & Health Insurers
      • 13.2.4. Diagnostic & Imaging Centers
      • 13.2.5. Medical Device & Digital Health Companies
      • 13.2.6. Research Institutions & Academic Medical Centers
      • 13.2.7. Government & Public Health Agencies
      • 13.2.8. Clinics & Ambulatory Care Centers
      • 13.2.9. Others
  • 14. Global Medical AI Governance Market Analysis and Forecasts, by Region
    • 14.1. Key Findings
    • 14.2. Medical AI Governance Market Size Value (US$ Bn), Analysis, and Forecasts, by Region, 2021-2035
      • 14.2.1. North America
      • 14.2.2. Europe
      • 14.2.3. Asia Pacific
      • 14.2.4. Middle East
      • 14.2.5. Africa
      • 14.2.6. South America
  • 15. North America Medical AI Governance Market Analysis
    • 15.1. Key Segment Analysis
    • 15.2. Regional Snapshot
    • 15.3. North America Medical AI Governance Market Size- Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 15.3.1. Governance Type
      • 15.3.2. Technology
      • 15.3.3. Deployment Mode
      • 15.3.4. AI Model
      • 15.3.5. Risk Classification
      • 15.3.6. Regulatory Framework Alignment
      • 15.3.7. Organization Size
      • 15.3.8. End-users
      • 15.3.9. Country
        • 15.3.9.1. USA
        • 15.3.9.2. Canada
        • 15.3.9.3. Mexico
    • 15.4. USA Medical AI Governance Market
      • 15.4.1. Country Segmental Analysis
      • 15.4.2. Governance Type
      • 15.4.3. Technology
      • 15.4.4. Deployment Mode
      • 15.4.5. AI Model
      • 15.4.6. Risk Classification
      • 15.4.7. Regulatory Framework Alignment
      • 15.4.8. Organization Size
      • 15.4.9. End-users
    • 15.5. Canada Medical AI Governance Market
      • 15.5.1. Country Segmental Analysis
      • 15.5.2. Governance Type
      • 15.5.3. Technology
      • 15.5.4. Deployment Mode
      • 15.5.5. AI Model
      • 15.5.6. Risk Classification
      • 15.5.7. Regulatory Framework Alignment
      • 15.5.8. Organization Size
      • 15.5.9. End-users
    • 15.6. Mexico Medical AI Governance Market
      • 15.6.1. Country Segmental Analysis
      • 15.6.2. Governance Type
      • 15.6.3. Technology
      • 15.6.4. Deployment Mode
      • 15.6.5. AI Model
      • 15.6.6. Risk Classification
      • 15.6.7. Regulatory Framework Alignment
      • 15.6.8. Organization Size
      • 15.6.9. End-users
  • 16. Europe Medical AI Governance Market Analysis
    • 16.1. Key Segment Analysis
    • 16.2. Regional Snapshot
    • 16.3. Europe Medical AI Governance Market Size Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 16.3.1. Governance Type
      • 16.3.2. Technology
      • 16.3.3. Deployment Mode
      • 16.3.4. AI Model
      • 16.3.5. Risk Classification
      • 16.3.6. Regulatory Framework Alignment
      • 16.3.7. Organization Size
      • 16.3.8. End-users
      • 16.3.9. Country
        • 16.3.9.1. Germany
        • 16.3.9.2. United Kingdom
        • 16.3.9.3. France
        • 16.3.9.4. Italy
        • 16.3.9.5. Spain
        • 16.3.9.6. Netherlands
        • 16.3.9.7. Nordic Countries
        • 16.3.9.8. Poland
        • 16.3.9.9. Russia & CIS
        • 16.3.9.10. Rest of Europe
    • 16.4. Germany Medical AI Governance Market
      • 16.4.1. Country Segmental Analysis
      • 16.4.2. Governance Type
      • 16.4.3. Technology
      • 16.4.4. Deployment Mode
      • 16.4.5. AI Model
      • 16.4.6. Risk Classification
      • 16.4.7. Regulatory Framework Alignment
      • 16.4.8. Organization Size
      • 16.4.9. End-users
    • 16.5. United Kingdom Medical AI Governance Market
      • 16.5.1. Country Segmental Analysis
      • 16.5.2. Governance Type
      • 16.5.3. Technology
      • 16.5.4. Deployment Mode
      • 16.5.5. AI Model
      • 16.5.6. Risk Classification
      • 16.5.7. Regulatory Framework Alignment
      • 16.5.8. Organization Size
      • 16.5.9. End-users
    • 16.6. France Medical AI Governance Market
      • 16.6.1. Country Segmental Analysis
      • 16.6.2. Governance Type
      • 16.6.3. Technology
      • 16.6.4. Deployment Mode
      • 16.6.5. AI Model
      • 16.6.6. Risk Classification
      • 16.6.7. Regulatory Framework Alignment
      • 16.6.8. Organization Size
      • 16.6.9. End-users
    • 16.7. Italy Medical AI Governance Market
      • 16.7.1. Country Segmental Analysis
      • 16.7.2. Governance Type
      • 16.7.3. Technology
      • 16.7.4. Deployment Mode
      • 16.7.5. AI Model
      • 16.7.6. Risk Classification
      • 16.7.7. Regulatory Framework Alignment
      • 16.7.8. Organization Size
      • 16.7.9. End-users
    • 16.8. Spain Medical AI Governance Market
      • 16.8.1. Country Segmental Analysis
      • 16.8.2. Governance Type
      • 16.8.3. Technology
      • 16.8.4. Deployment Mode
      • 16.8.5. AI Model
      • 16.8.6. Risk Classification
      • 16.8.7. Regulatory Framework Alignment
      • 16.8.8. Organization Size
      • 16.8.9. End-users
    • 16.9. Netherlands Medical AI Governance Market
      • 16.9.1. Country Segmental Analysis
      • 16.9.2. Governance Type
      • 16.9.3. Technology
      • 16.9.4. Deployment Mode
      • 16.9.5. AI Model
      • 16.9.6. Risk Classification
      • 16.9.7. Regulatory Framework Alignment
      • 16.9.8. Organization Size
      • 16.9.9. End-users
    • 16.10. Nordic Countries Medical AI Governance Market
      • 16.10.1. Country Segmental Analysis
      • 16.10.2. Governance Type
      • 16.10.3. Technology
      • 16.10.4. Deployment Mode
      • 16.10.5. AI Model
      • 16.10.6. Risk Classification
      • 16.10.7. Regulatory Framework Alignment
      • 16.10.8. Organization Size
      • 16.10.9. End-users
    • 16.11. Poland Medical AI Governance Market
      • 16.11.1. Country Segmental Analysis
      • 16.11.2. Governance Type
      • 16.11.3. Technology
      • 16.11.4. Deployment Mode
      • 16.11.5. AI Model
      • 16.11.6. Risk Classification
      • 16.11.7. Regulatory Framework Alignment
      • 16.11.8. Organization Size
      • 16.11.9. End-users
    • 16.12. Russia & CIS Medical AI Governance Market
      • 16.12.1. Country Segmental Analysis
      • 16.12.2. Governance Type
      • 16.12.3. Technology
      • 16.12.4. Deployment Mode
      • 16.12.5. AI Model
      • 16.12.6. Risk Classification
      • 16.12.7. Regulatory Framework Alignment
      • 16.12.8. Organization Size
      • 16.12.9. End-users
    • 16.13. Rest of Europe Medical AI Governance Market
      • 16.13.1. Country Segmental Analysis
      • 16.13.2. Governance Type
      • 16.13.3. Technology
      • 16.13.4. Deployment Mode
      • 16.13.5. AI Model
      • 16.13.6. Risk Classification
      • 16.13.7. Regulatory Framework Alignment
      • 16.13.8. Organization Size
      • 16.13.9. End-users
  • 17. Asia Pacific Medical AI Governance Market Analysis
    • 17.1. Key Segment Analysis
    • 17.2. Regional Snapshot
    • 17.3. Asia Pacific Medical AI Governance Market Size Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 17.3.1. Governance Type
      • 17.3.2. Technology
      • 17.3.3. Deployment Mode
      • 17.3.4. AI Model
      • 17.3.5. Risk Classification
      • 17.3.6. Regulatory Framework Alignment
      • 17.3.7. Organization Size
      • 17.3.8. End-users
      • 17.3.9. Country
        • 17.3.9.1. China
        • 17.3.9.2. India
        • 17.3.9.3. Japan
        • 17.3.9.4. South Korea
        • 17.3.9.5. Australia and New Zealand
        • 17.3.9.6. Indonesia
        • 17.3.9.7. Malaysia
        • 17.3.9.8. Thailand
        • 17.3.9.9. Vietnam
        • 17.3.9.10. Rest of Asia Pacific
    • 17.4. China Medical AI Governance Market
      • 17.4.1. Country Segmental Analysis
      • 17.4.2. Governance Type
      • 17.4.3. Technology
      • 17.4.4. Deployment Mode
      • 17.4.5. AI Model
      • 17.4.6. Risk Classification
      • 17.4.7. Regulatory Framework Alignment
      • 17.4.8. Organization Size
      • 17.4.9. End-users
    • 17.5. India Medical AI Governance Market
      • 17.5.1. Country Segmental Analysis
      • 17.5.2. Governance Type
      • 17.5.3. Technology
      • 17.5.4. Deployment Mode
      • 17.5.5. AI Model
      • 17.5.6. Risk Classification
      • 17.5.7. Regulatory Framework Alignment
      • 17.5.8. Organization Size
      • 17.5.9. End-users
    • 17.6. Japan Medical AI Governance Market
      • 17.6.1. Country Segmental Analysis
      • 17.6.2. Governance Type
      • 17.6.3. Technology
      • 17.6.4. Deployment Mode
      • 17.6.5. AI Model
      • 17.6.6. Risk Classification
      • 17.6.7. Regulatory Framework Alignment
      • 17.6.8. Organization Size
      • 17.6.9. End-users
    • 17.7. South Korea Medical AI Governance Market
      • 17.7.1. Country Segmental Analysis
      • 17.7.2. Governance Type
      • 17.7.3. Technology
      • 17.7.4. Deployment Mode
      • 17.7.5. AI Model
      • 17.7.6. Risk Classification
      • 17.7.7. Regulatory Framework Alignment
      • 17.7.8. Organization Size
      • 17.7.9. End-users
    • 17.8. Australia and New Zealand Medical AI Governance Market
      • 17.8.1. Country Segmental Analysis
      • 17.8.2. Governance Type
      • 17.8.3. Technology
      • 17.8.4. Deployment Mode
      • 17.8.5. AI Model
      • 17.8.6. Risk Classification
      • 17.8.7. Regulatory Framework Alignment
      • 17.8.8. Organization Size
      • 17.8.9. End-users
    • 17.9. Indonesia Medical AI Governance Market
      • 17.9.1. Country Segmental Analysis
      • 17.9.2. Governance Type
      • 17.9.3. Technology
      • 17.9.4. Deployment Mode
      • 17.9.5. AI Model
      • 17.9.6. Risk Classification
      • 17.9.7. Regulatory Framework Alignment
      • 17.9.8. Organization Size
      • 17.9.9. End-users
    • 17.10. Malaysia Medical AI Governance Market
      • 17.10.1. Country Segmental Analysis
      • 17.10.2. Governance Type
      • 17.10.3. Technology
      • 17.10.4. Deployment Mode
      • 17.10.5. AI Model
      • 17.10.6. Risk Classification
      • 17.10.7. Regulatory Framework Alignment
      • 17.10.8. Organization Size
      • 17.10.9. End-users
    • 17.11. Thailand Medical AI Governance Market
      • 17.11.1. Country Segmental Analysis
      • 17.11.2. Governance Type
      • 17.11.3. Technology
      • 17.11.4. Deployment Mode
      • 17.11.5. AI Model
      • 17.11.6. Risk Classification
      • 17.11.7. Regulatory Framework Alignment
      • 17.11.8. Organization Size
      • 17.11.9. End-users
    • 17.12. Vietnam Medical AI Governance Market
      • 17.12.1. Country Segmental Analysis
      • 17.12.2. Governance Type
      • 17.12.3. Technology
      • 17.12.4. Deployment Mode
      • 17.12.5. AI Model
      • 17.12.6. Risk Classification
      • 17.12.7. Regulatory Framework Alignment
      • 17.12.8. Organization Size
      • 17.12.9. End-users
    • 17.13. Rest of Asia Pacific Medical AI Governance Market
      • 17.13.1. Country Segmental Analysis
      • 17.13.2. Governance Type
      • 17.13.3. Technology
      • 17.13.4. Deployment Mode
      • 17.13.5. AI Model
      • 17.13.6. Risk Classification
      • 17.13.7. Regulatory Framework Alignment
      • 17.13.8. Organization Size
      • 17.13.9. End-users
  • 18. Middle East Medical AI Governance Market Analysis
    • 18.1. Key Segment Analysis
    • 18.2. Regional Snapshot
    • 18.3. Middle East Medical AI Governance Market Size Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 18.3.1. Governance Type
      • 18.3.2. Technology
      • 18.3.3. Deployment Mode
      • 18.3.4. AI Model
      • 18.3.5. Risk Classification
      • 18.3.6. Regulatory Framework Alignment
      • 18.3.7. Organization Size
      • 18.3.8. End-users
      • 18.3.9. Country
        • 18.3.9.1. Turkey
        • 18.3.9.2. UAE
        • 18.3.9.3. Saudi Arabia
        • 18.3.9.4. Israel
        • 18.3.9.5. Rest of Middle East
    • 18.4. Turkey Medical AI Governance Market
      • 18.4.1. Copilot Type
      • 18.4.2. Governance Type
      • 18.4.3. Technology
      • 18.4.4. Deployment Mode
      • 18.4.5. AI Model
      • 18.4.6. Risk Classification
      • 18.4.7. Regulatory Framework Alignment
      • 18.4.8. Organization Size
      • 18.4.9. End-users
    • 18.5. UAE Medical AI Governance Market
      • 18.5.1. Country Segmental Analysis
      • 18.5.2. Governance Type
      • 18.5.3. Technology
      • 18.5.4. Deployment Mode
      • 18.5.5. AI Model
      • 18.5.6. Risk Classification
      • 18.5.7. Regulatory Framework Alignment
      • 18.5.8. Organization Size
      • 18.5.9. End-users
    • 18.6. Saudi Arabia Medical AI Governance Market
      • 18.6.1. Country Segmental Analysis
      • 18.6.2. Governance Type
      • 18.6.3. Technology
      • 18.6.4. Deployment Mode
      • 18.6.5. AI Model
      • 18.6.6. Risk Classification
      • 18.6.7. Regulatory Framework Alignment
      • 18.6.8. Organization Size
      • 18.6.9. End-users
    • 18.7. Israel Medical AI Governance Market
      • 18.7.1. Country Segmental Analysis
      • 18.7.2. Governance Type
      • 18.7.3. Technology
      • 18.7.4. Deployment Mode
      • 18.7.5. AI Model
      • 18.7.6. Risk Classification
      • 18.7.7. Regulatory Framework Alignment
      • 18.7.8. Organization Size
      • 18.7.9. End-users
    • 18.8. Rest of Middle East Medical AI Governance Market
      • 18.8.1. Country Segmental Analysis
      • 18.8.2. Governance Type
      • 18.8.3. Technology
      • 18.8.4. Deployment Mode
      • 18.8.5. AI Model
      • 18.8.6. Risk Classification
      • 18.8.7. Regulatory Framework Alignment
      • 18.8.8. Organization Size
      • 18.8.9. End-users
  • 19. Africa Medical AI Governance Market Analysis
    • 19.1. Key Segment Analysis
    • 19.2. Regional Snapshot
    • 19.3. Africa Medical AI Governance Market Size Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 19.3.1. Governance Type
      • 19.3.2. Technology
      • 19.3.3. Deployment Mode
      • 19.3.4. AI Model
      • 19.3.5. Risk Classification
      • 19.3.6. Regulatory Framework Alignment
      • 19.3.7. Organization Size
      • 19.3.8. End-users
      • 19.3.9. Country
        • 19.3.9.1. South Africa
        • 19.3.9.2. Egypt
        • 19.3.9.3. Nigeria
        • 19.3.9.4. Algeria
        • 19.3.9.5. Rest of Africa
    • 19.4. South Africa Medical AI Governance Market
      • 19.4.1. Country Segmental Analysis
      • 19.4.2. Governance Type
      • 19.4.3. Technology
      • 19.4.4. Deployment Mode
      • 19.4.5. AI Model
      • 19.4.6. Risk Classification
      • 19.4.7. Regulatory Framework Alignment
      • 19.4.8. Organization Size
      • 19.4.9. End-users
    • 19.5. Egypt Medical AI Governance Market
      • 19.5.1. Country Segmental Analysis
      • 19.5.2. Governance Type
      • 19.5.3. Technology
      • 19.5.4. Deployment Mode
      • 19.5.5. AI Model
      • 19.5.6. Risk Classification
      • 19.5.7. Regulatory Framework Alignment
      • 19.5.8. Organization Size
      • 19.5.9. End-users
    • 19.6. Nigeria Medical AI Governance Market
      • 19.6.1. Country Segmental Analysis
      • 19.6.2. Governance Type
      • 19.6.3. Technology
      • 19.6.4. Deployment Mode
      • 19.6.5. AI Model
      • 19.6.6. Risk Classification
      • 19.6.7. Regulatory Framework Alignment
      • 19.6.8. Organization Size
      • 19.6.9. End-users
    • 19.7. Algeria Medical AI Governance Market
      • 19.7.1. Country Segmental Analysis
      • 19.7.2. Governance Type
      • 19.7.3. Technology
      • 19.7.4. Deployment Mode
      • 19.7.5. AI Model
      • 19.7.6. Risk Classification
      • 19.7.7. Regulatory Framework Alignment
      • 19.7.8. Organization Size
      • 19.7.9. End-users
    • 19.8. Rest of Africa Medical AI Governance Market
      • 19.8.1. Country Segmental Analysis
      • 19.8.2. Governance Type
      • 19.8.3. Technology
      • 19.8.4. Deployment Mode
      • 19.8.5. AI Model
      • 19.8.6. Risk Classification
      • 19.8.7. Regulatory Framework Alignment
      • 19.8.8. Organization Size
      • 19.8.9. End-users
  • 20. South America Medical AI Governance Market Analysis
    • 20.1. Key Segment Analysis
    • 20.2. Regional Snapshot
    • 20.3. South America Medical AI Governance Market Size Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 20.3.1. Governance Type
      • 20.3.2. Technology
      • 20.3.3. Deployment Mode
      • 20.3.4. AI Model
      • 20.3.5. Risk Classification
      • 20.3.6. Regulatory Framework Alignment
      • 20.3.7. Organization Size
      • 20.3.8. End-users
      • 20.3.9. Country
        • 20.3.9.1. Brazil
        • 20.3.9.2. Argentina
        • 20.3.9.3. Rest of South America
    • 20.4. Brazil Medical AI Governance Market
      • 20.4.1. Country Segmental Analysis
      • 20.4.2. Governance Type
      • 20.4.3. Technology
      • 20.4.4. Deployment Mode
      • 20.4.5. AI Model
      • 20.4.6. Risk Classification
      • 20.4.7. Regulatory Framework Alignment
      • 20.4.8. Organization Size
      • 20.4.9. End-users
    • 20.5. Argentina Medical AI Governance Market
      • 20.5.1. Country Segmental Analysis
      • 20.5.2. Governance Type
      • 20.5.3. Technology
      • 20.5.4. Deployment Mode
      • 20.5.5. AI Model
      • 20.5.6. Risk Classification
      • 20.5.7. Regulatory Framework Alignment
      • 20.5.8. Organization Size
      • 20.5.9. End-users
    • 20.6. Rest of South America Medical AI Governance Market
      • 20.6.1. Country Segmental Analysis
      • 20.6.2. Governance Type
      • 20.6.3. Technology
      • 20.6.4. Deployment Mode
      • 20.6.5. AI Model
      • 20.6.6. Risk Classification
      • 20.6.7. Regulatory Framework Alignment
      • 20.6.8. Organization Size
      • 20.6.9. End-users
  • 21. Key Players/ Company Profile
    • 21.1. Pacific AI
      • 21.1.1. Company Details/ Overview
      • 21.1.2. Company Financials
      • 21.1.3. Key Customers and Competitors
      • 21.1.4. Business/ Industry Portfolio
      • 21.1.5. Product Portfolio/ Specification Details
      • 21.1.6. Pricing Data
      • 21.1.7. Strategic Overview
      • 21.1.8. Recent Developments
    • 21.2. ALIGNMT AI
    • 21.3. Amazon Web Services
    • 21.4. Complira
    • 21.5. Credo AI
    • 21.6. Ferrum Health
    • 21.7. Fiddler AI
    • 21.8. Google
    • 21.9. IBM
    • 21.10. Microsoft
    • 21.11. Newton’s Tree
    • 21.12. Onboard AI
    • 21.13. Signal 1
    • 21.14. Synergist Technology
    • 21.15. Other Key Players

 

Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography

Get PDF
PRICING DETAILS
USD 4150
USD 5950
USD 7750
Related Report  
YOU MAY ALSO LIKE
Algae Protein Market by Source Type, Form, Protein Content, Production Method, Nature, Extraction Technology, Grade, End-Use Industry, and Geography
Alternative Protein Market by Source/Type, Form, Product Type, Processing Technology, Distribution Channel, Protein Content, End-users, and Geography
Astaxanthin Market by Source/Origin, Form, Grade/Purity Level, Concentration Level, Production Technology, End-users, Distribution Channel, Packaging Type, and Geography
Discount On Multiple Reports

Where did We Help Most?

Custom Market Research Services

We will customise the research for you, in case the report listed above does not meet your requirements.

Get 10% Free Customisation